T-CELL RESPONSE OF ADVANCED AIDS PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

被引:1
作者
Ai-xia Wang*
机构
关键词
acquired immune deficiency syndrome; highly active antiretroviral therapy; immune reconstitution;
D O I
暂无
中图分类号
R512.91 [获得性免疫缺陷综合征(AIDS艾滋病)];
学科分类号
100401 ;
摘要
Objective To investigate the response on late stage Chinese AIDS patients after highly active antiretroviral therapy (HAART). Methods From October 2002 to March 2004, 20 cases of late stage Chinese AIDS patients were selected to particip-ate in this opened and randomised study, we purposely chose those with CD4+ T cell counts < 100/mm3. All of them had one or two opportunistic infections and none had been treated with anti-HIV drugs. All patients were tested with CD4+ (naive CD4+ T cell defined by CD45RA+ and CD62L+, memory CD4+ T cell defined by CD45RA-), CD8+ T cell, plasma HIV viral load, and clinical manifestations on before, during, and after HAART (5 different regimes) on 1, 3, 6, 9, and 12 months. Results Before HAART mean CD4+ T cell counts were 32 ± 31(range 2-91)/mm3, and plasma HIV viral load were 5.07 ± 0.85(range 2.04-5.70) log copies/mL. In 1 month’s time patients treated with HAART had mean CD4+ and CD8+ T cell counts increasing rapidly. After 1 month the increasing speed turned to slow down, but HIV viral load decreased predominantly within the first 3 months. The major part of increasing CD4+ T cells were memory CD4+ T cells, as for naive CD4+ T cells increasing low and slow. Clinical symptoms and signs improved, and opportunistic infections reduced. The quality of life will be far much better than before. Each patient was followed for 12 months, and had finished 12 months’ HAART. Conclusion This is the first report in China that late stage Chinese AIDS patients after HAART could have their immune reconstitution. The regular pattern is similar to what had been reported in Western countries and also in China. So it is worth to treat late stage Chinese AIDS patients with HAART.
引用
收藏
页码:223 / 225
页数:3
相关论文
共 50 条
  • [21] Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated by highly active antiretroviral therapy
    Badelon, I
    Gohier, P
    Chaine, G
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1999, 22 (10): : 1034 - 1041
  • [22] Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma
    Skiest, DJ
    Crosby, C
    AIDS, 2003, 17 (12) : 1787 - 1793
  • [23] Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy
    Sheng, WH
    Hung, CC
    Chen, MY
    Hsieh, SM
    Chang, SC
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (10) : 702 - 705
  • [24] Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese
    Lin, Yu-Chi
    Yang, Chang-Hao
    Lin, Chang-Ping
    Yang, Chung-May
    Chen, Muh-Shy
    Chen, Mao-Yuan
    Sheng, Wang-Huei
    Hung, Chien-Ching
    Chang, Shan-Chwen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2008, 16 (03) : 83 - 87
  • [25] Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy
    Duran, A. C. F. L.
    Almeida, L. B.
    Segurado, A. A. C.
    Jaime, P. C.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2008, 21 (04) : 346 - 350
  • [26] Virological rebound after suppression on highly active antiretroviral therapy
    Mocroft, A
    Ruiz, L
    Reiss, P
    Ledergerber, B
    Katlama, C
    Lazzarin, A
    Goebel, FD
    Phillips, AN
    Clotet, B
    Lundgren, JD
    AIDS, 2003, 17 (12) : 1741 - 1751
  • [27] Cessation of anti-cytomegalovirus maintenance therapy in AIDS patients with cytomegalovirus retinitis healed by highly active antiretroviral therapy
    Best, J
    Althaus, C
    Kersten, A
    Theisen, A
    Gantke, B
    OPHTHALMOLOGE, 2000, 97 (08): : 574 - 576
  • [28] Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study
    Li, XH
    Margolick, JB
    Conover, CS
    Badri, S
    Riddler, SA
    Witt, MD
    Jacobson, LP
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (03) : 320 - 328
  • [29] Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy
    Berenguer, Juan
    Miralles, Pilar
    Ribera, Jose Maria
    Rubio, Rafael
    Valencia, Eulalia
    Mahillo, Beatriz
    Pintado, Vicente
    Palacios, Rosario
    Montes, Maria Luisa
    Tellez, Maria Jesus
    La Cruz, Jose
    Torre-Cisneros, Julian
    Rodriguez-Arrondo, Francisco
    Sepulveda, Maria Antonia
    Gutierrez, Felix
    Peralta, Galo
    Boix, Vicente
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (04) : 422 - 428
  • [30] Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy
    van Leth, F
    Wit, FWNM
    Reiss, P
    Schattenkerk, JKME
    van der Ende, ME
    Schneider, MME
    Mulder, JW
    Frissen, PHJ
    deWolf, F
    Lange, JMA
    HIV MEDICINE, 2004, 5 (02) : 74 - 81